Xylem Inc.
NYSE:XYLIndustrial - Machinery
+$1.04 today
- Market cap
- $21.83B
- Beta
- 1.04
- P/E (TTM)
- 27.8
- EPS (TTM)
- $4.01
- Dividend yield
- 1.49%
Volume 2.70M
Average 2.15M
XYL Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
Xylem Inc.NYSE: XYL
Cash & Equivalents · Q2 FY2026 · quarter ended Jun 2026
Cash & equivalents rises 9.1% from a year ago
Cash & equivalents stood at $1.28B at the end of Q2 FY2026, up 9.1% from a year earlier and up 57.9% from the prior quarter. Over 3 fiscal years it compounded at +16.1% a year.
Context
- Cash & equivalents amounted to 7.4% of total assets at the end of Q2 FY2026, up 0.6 pp from a year earlier.
- Cash & equivalents increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether cash & equivalents keeps rising in the next quarterly balance sheet after a +9.1% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2025
- 1.48B USD
- Year-over-year change
- +31.9%
- 4-year CAGR
- +2.3%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.48B | +31.9% |
| FY2024 | 2024-12-31 | 1.12B | +10.0% |
| FY2023 | 2023-12-31 | 1.02B | +7.9% |
| FY2022 | 2022-12-31 | 944M | -30.0% |
| FY2021 | 2021-12-31 | 1.35B | — |
Cash & Equivalents vs competitors
How XYL compares with its peers on the latest reported figures
- XYL's Jun 2026 cash & equivalents of $1.28B is the 2nd highest of the 9 companies compared; the peer median is $456.95M.
- Its year-over-year change of +9.1% is the 7th highest of 9, against a peer median of +17.1%.
- Cash & equivalents amounts to 7.4% of total assets for XYL, versus a peer median of 11.3%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jul 2026 | $2.12B | +35.9% | — | 24.8% | |
| Jun 2026 | $1.28B | +9.1% | +16.1% | 7.4% | |
| Jun 2026 | $731.01M | +16.2% | +20.5% | 11.6% | |
| Jun 2026 | $621.3M | +9.3% | +10.5% | 9.0% | |
| Sep 2026 | $566M | +31.2% | +52.3% | 27.9% | |
| Jun 2026 | $347.9M | -5.8% | +9.3% | 11.8% | |
| Sep 2026 | $307.1M | +18.1% | +34.0% | 10.9% | |
| Sep 2026 | $159.1M | +54.6% | +29.6% | 6.0% | |
| Sep 2026 | $74M | -42.4% | -2.3% | 1.1% | |
| Peer median (excluding XYL) | $456.95M | +17.1% | +20.5% | 11.3% | |
Competitors are the stored peer set for XYL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 1.35B | 944M | 1.02B | 1.12B | 1.48B |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 953M | 1.1B | 1.62B | 1.67B | 1.76B |
| Inventory | 700M | 799M | 1.02B | 996M | 983M |
| Other Current Assets | 0 | 173M | 230M | 309M | 176M |
| Total Current Assets | 3.16B | 3.01B | 3.88B | 4.09B | 4.64B |
| Property, Plant & Equipment (Net) | 644M | 630M | 1.17B | 1.15B | 1.55B |
| Goodwill | 2.79B | 2.72B | 7.59B | 7.98B | 8.33B |
| Intangible Assets | 1.02B | 930M | 2.53B | 2.38B | 2.27B |
| Long-term Investments | 8M | 79M | 9M | 50M | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 141M |
| Other Non-current Assets | 656M | 582M | 934M | 834M | 698M |
| Total Non-current Assets | 5.12B | 4.94B | 12.23B | 12.4B | 12.99B |
| Total Assets | 8.28B | 7.95B | 16.11B | 16.49B | 17.63B |
| Account Payables | 639M | 723M | 968M | 1.01B | 1.01B |
| Short-term Debt | 69M | 69M | 16M | 38M | 534M |
| Tax Payables | 86M | 186M | 170M | 201M | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 273M | 285M | 403M | 430M | 443M |
| Total Current Liabilities | 1.39B | 1.59B | 2.21B | 2.34B | 2.86B |
| Long-term Debt | 2.44B | 1.88B | 2.27B | 1.98B | 1.41B |
| Deferred Tax Liabilities | 287M | 222M | 557M | 497M | 405M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 932M | 757M | 906M | 800M | 1.22B |
| Total Non-current Liabilities | 3.66B | 2.86B | 3.73B | 3.28B | 3.03B |
| Total Liabilities | 5.05B | 4.45B | 5.94B | 5.62B | 5.89B |
| Common Stock | 2M | 2M | 3M | 3M | 3M |
| Retained Earnings | 2.15B | 2.29B | 2.6B | 3.14B | 3.71B |
| Accumulated OCI | (371M) | (226M) | (269M) | (435M) | (220M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 8M | 9M | 10M | 240M | 269M |
| Total Equity | 3.23B | 3.5B | 10.18B | 10.88B | 11.75B |
| Total Debt | 2.51B | 1.95B | 2.39B | 2.13B | 2.06B |
| Net Debt | 1.16B | 1.01B | 1.37B | 1B | 584M |
Xylem Inc.
NYSE:XYL
Intrinsic Alpha fair value
Locked
Current Price
$95.20
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.